FDA Inspection 1028540 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on July 26, 2017 in Las Cruces, NM. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 26, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Las Cruces, NM (United States)